These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32880878)

  • 1. How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton.
    Roope LSJ; Buckell J; Becker F; Candio P; Violato M; Sindelar JL; Barnett A; Duch R; Clarke PM
    Pharmacoecon Open; 2020 Dec; 4(4):557-561. PubMed ID: 32880878
    [No Abstract]   [Full Text] [Related]  

  • 2. Editor's Choice: Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey.
    Kwok KO; Li KK; Wei WI; Tang A; Wong SYS; Lee SS
    Int J Nurs Stud; 2021 Feb; 114():103854. PubMed ID: 33326864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical affairs post-COVID 19: Are we ready to take the baton?
    Rajadhyaksha VD
    Perspect Clin Res; 2020; 11(3):124-127. PubMed ID: 33033702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Vaccine Hesitancy in an Underrepresented Minority Community.
    Balhotra K; Chahal K; Silver M; Atallah F; Narayanamoorthy S; Minkoff H
    J Community Health; 2023 Jun; 48(3):489-495. PubMed ID: 36692822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to Take COVID-19 Vaccine Among People Most at Risk of Exposure in Southern Ethiopia.
    Zewude B; Habtegiorgis T
    Pragmat Obs Res; 2021; 12():37-47. PubMed ID: 34079423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public Willingness and Hesitancy to Take the COVID-19 Vaccine in Afghanistan.
    Nemat A; Bahez A; Salih M; Raufi N; Noor NAS; Essar MY; Ehsan E; Asady A
    Am J Trop Med Hyg; 2021 Jul; 105(3):713-717. PubMed ID: 34237016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with intention to take COVID-19 vaccine among the university students in Bangladesh.
    Shuvo NA; Mondal MSH
    Clin Exp Vaccine Res; 2022 Sep; 11(3):274-284. PubMed ID: 36451669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Vaccine Intent Among Health Care Professionals of Queen Elizabeth Hospital, Barbados.
    Krishnamurthy K; Sobers N; Kumar A; Ojeh N; Scott A; Cave C; Gupta S; Bradford-King J; Sa B; Adams OP; Campbell MH; Majumder MAA
    J Multidiscip Healthc; 2021; 14():3309-3319. PubMed ID: 34876817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment.
    Ouyang J; Isnard S; Lin J; Fombuena B; Peng X; Routy JP; Chen Y
    Front Immunol; 2020; 11():570063. PubMed ID: 33072111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covid-19 vaccine trials and ethics: Protection delayed is protection denied.
    John TJ; Dharmapalan D
    Indian J Med Ethics; 2021; VI(1):1-5. PubMed ID: 34080997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moving beyond Aim Three: a need for a transdisciplinary approach to build capacity for economic evaluations in implementation science.
    Barnett ML; Stadnick NA; Proctor EK; Dopp AR; Saldana L
    Implement Sci Commun; 2021 Dec; 2(1):133. PubMed ID: 34863315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of Health Belief Model (HBM) to explain factors underlying people to take the COVID-19 vaccine in Indonesia.
    Adiyoso W; Wilopo W; Mondry ; Nurbaiti B; Suprapto FA
    Vaccine X; 2023 Aug; 14():100297. PubMed ID: 37063303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An editorial farewell: Ready to pass the baton.
    Iskandrian AE
    J Nucl Cardiol; 2023 Feb; 30(1):1-9. PubMed ID: 36482238
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing by Pharmacist's and Collaborative Care: Are We Ready to Accept the Baton and Get in the Race?
    Barry AR; Pearson GJ
    Can J Hosp Pharm; 2010 Jan; 63(1):59. PubMed ID: 22478957
    [No Abstract]   [Full Text] [Related]  

  • 17. Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia.
    Strupat C; Shigute Z; Bedi AS; Rieger M
    PLoS One; 2022; 17(3):e0264633. PubMed ID: 35239711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine.
    Cordina M; Lauri MA; Lauri J
    Pharm Pract (Granada); 2021; 19(1):2317. PubMed ID: 33828623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the Factors That Predict the Intention to Take COVID-19 Vaccine in Nigeria.
    Apuke OD; Asude Tunca E
    J Asian Afr Stud; 2023 Aug; 58(5):664-680. PubMed ID: 37461427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborating with health economists to advance implementation science: a qualitative study.
    Barnett ML; Dopp AR; Klein C; Ettner SL; Powell BJ; Saldana L
    Implement Sci Commun; 2020; 1():82. PubMed ID: 33005901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.